New study of Ebola may hold answers for long-term COVID-19 immunity

The study, carried out in a joint effort by British and Guinean scientists, is the world's largest and most comprehensive one to date to examine survivors of the Ebola virus.

Nano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells leading to activation of T cells to recognize and attack melanoma.

(photo credit: PROF. SATCHI-FAINARO)

ByTOBIAS SIEGAL

OCTOBER 22, 2020 13:53

RECOMMENDED STORIES

Israel at War - Illustrative image of an Israeli F-35 fighter jet.

Israel's defense industry eyes new partners for next-gen fighter jet by 2028

JULY 30, 2025

Leonardo DiCaprio stands on stage during the opening ceremony and the screening the film "Partir un jour" (Leave One Day) Out of competition at the 78th Cannes Film Festival in Cannes, France, May 13, 2025.

Leonardo DiCaprio to open hotel in Israel

JULY 29, 2025

Child Muhammad Zakariya Ayyoub al-Matouq, who suffers from cerebral palsy, alongside mother and brother.

NYT quietly alters Gaza starvation story to include key details of child's medical condition

JULY 30, 2025

Auschwitz concentration camp, operated by Nazi Germany in occupied Poland during the Holocaust.

California governor candidate calls Auschwitz 'solution for homelessness,' sparks critisism

JULY 27, 2025

New study of Ebola may hold answers for long-term COVID-19 immunity

The study, carried out in a joint effort by British and Guinean scientists, is the world's largest and most comprehensive one to date to examine survivors of the Ebola virus.

Gov't unanimously votes to dismiss Baharav-Miara

Kibbutz Nahal Oz petitions against Gaza border repopulation

New study of Ebola may hold answers for long-term COVID-19 immunity

The study, carried out in a joint effort by British and Guinean scientists, is the world's largest and most comprehensive one to date to examine survivors of the Ebola virus.

See more on